Premium
Actis Advisers Pvt. Ltd is in the final stages of negotiations with a consortium of fellow private equity firms to sell its stake in bulk drugs maker Symbiotec Pharmalab Pvt. Ltd, three people familiar with the development told VCCircle. A consortium comprising healthcare-focussed InvAscent and sector-agnostic Motilal Oswal Private Equity is ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
